Male | Female | |||||||
---|---|---|---|---|---|---|---|---|
Always | Frequently | Infrequently | Never | Always | Frequently | Infrequently | Never | |
General prescribing | 22 % (37/167) | 46 % (77/167) | 25 % (41/167) | 7 % (11/167) | 21 % (40/190) | 51 % (97/190) | 22 % (42/190) | 6 % (12/190) |
In the case of a treatment failure | 68 % (114/168) | 29 % (49/168) | 2 % (3/168) | 1 % (1/168) | 79 % (154/195) | 19 % (38/195) | 1 % (2/195) | 1 % (1/195) |
When resistance is reported to initial prescribed agent | 81 % (136/168) | 16 % (27/168) | 2 % (4/168) | 1 % (1/168) | 86 % (168/195) | 13 % (26/195) | 1 % (1/195) | 0 % (0/195) |